Cargando…

Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma

INTRODUCTION: Glioblastoma (GBM) is identified as a lethal malignant tumor derived from the nervous system. Despite the standard clinical strategy including maximum surgical resection, temozolomide (TMZ) chemotherapy, and radiotherapy, the median survival of GBM patients remains <15 months. Accum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alafate, Wahafu, Li, Xiaodong, Zuo, Jie, Zhang, Hua, Xiang, Jianyang, Wu, Wei, Xie, Wanfu, Bai, Xiaobin, Wang, Maode, Wang, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080429/ https://www.ncbi.nlm.nih.gov/pubmed/32187449 http://dx.doi.org/10.1111/cns.13297

Ejemplares similares

NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
por: Xiang, Jianyang, et al.
Publicado: (2022)

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
por: Wang, Jia, et al.
Publicado: (2019)

Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling
por: Alafate, Wahafu, et al.
Publicado: (2020)

Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas
por: Wu, Wei, et al.
Publicado: (2021)

Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020)

A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
por: Wu, Wei, et al.
Publicado: (2022)

FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling
por: Wang, Yichang, et al.
Publicado: (2021)

Development of prognostic indicator based on NAD+ metabolism related genes in glioma
por: Chen, Xiao, et al.
Publicado: (2023)

Polo-like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma
por: Wang, Jia, et al.
Publicado: (2019)

Mesenchymal stem cells over-expressing cxcl12 enhance the radioresistance of the small intestine
por: Chang, Pengyu, et al.
Publicado: (2018)

Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma
por: Bai, Xiaobin, et al.
Publicado: (2017)

Gene Expression Changes in Residual Advanced Cervical Cancer after Radiotherapy: Indicators of Poor Prognosis and Radioresistance?
por: Fu, Zhi-chao, et al.
Publicado: (2015)

Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer
por: Chen, Zhihui, et al.
Publicado: (2019)

TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
por: Zhang, Yufeng, et al.
Publicado: (2022)

Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma
por: Phan, Thi Le, et al.
Publicado: (2021)

Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma
por: Wang, Jia, et al.
Publicado: (2017)

DNA repair gene XRCC3 Thr241Met polymorphism and susceptibility to glioma: A case-control study
por: XU, GAOFENG, et al.
Publicado: (2014)

CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma
por: Li, Qi, et al.
Publicado: (2018)

Cathepsins Trigger Cell Death and Regulate Radioresistance in Glioblastoma
por: Ding, Xiaofeng, et al.
Publicado: (2022)

Radioresistance in Glioblastoma and the Development of Radiosensitizers
por: Ali, Md Yousuf, et al.
Publicado: (2020)

Bioinformatics analysis of microenvironment-related genes associated with radioresistance in glioblastoma
por: Liu, Yun, et al.
Publicado: (2020)

Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma
por: Wang, Jia, et al.
Publicado: (2016)

c-Fos over-expression promotes radioresistance and predicts poor prognosis in malignant glioma
por: Liu, Zhi-Gang, et al.
Publicado: (2016)

Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma
por: Chen, Qi, et al.
Publicado: (2019)

LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023)

Acid ceramidase confers radioresistance to glioblastoma cells
por: Doan, Ninh B., et al.
Publicado: (2017)

Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program
por: Stanzani, Elisabetta, et al.
Publicado: (2017)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma
por: Bottner, Justus, et al.
Publicado: (2022)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014)

CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer
por: Wu, Bin, et al.
Publicado: (2020)

Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer
por: You, Guo-Rung, et al.
Publicado: (2021)

TRPM8 is required for survival and radioresistance of glioblastoma cells
por: Klumpp, Dominik, et al.
Publicado: (2017)

Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients
por: Wang, Zhitao, et al.
Publicado: (2021)

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
por: Hu, Jiemiao, et al.
Publicado: (2021)

Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins
por: Zou, An, et al.
Publicado: (2014)

Over-expression of CXCL2 is associated with poor prognosis in patients with ovarian cancer
por: Zhang, Fenghua, et al.
Publicado: (2021)

Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma
por: Lee, I-Neng, et al.
Publicado: (2021)

Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients
por: Chen, Zhan-hong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2eos9t4p2rf7qtalm1hs40g3sb